Cargando…

Reproducibility of serial creatinine excretion measurements in peritoneal dialysis

AIM: To test whether muscle mass evaluated by creatinine excretion (EX(Cr)) is maintained in patients with end-stage kidney disease (ESKD) treated by peritoneal dialysis (PD), we evaluated repeated measurements of EX(Cr) in a PD population. METHODS: One hundred and sixty-six PD patients (94 male, 72...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Zhi, Murata, Glen H, Sun, Yijuan, Glew, Robert H, Qualls, Clifford, Vigil, Darlene, Servilla, Karen S, Golper, Thomas A, Tzamaloukas, Antonios H
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5500457/
https://www.ncbi.nlm.nih.gov/pubmed/28729968
http://dx.doi.org/10.5527/wjn.v6.i4.201
_version_ 1783248629135310848
author Xu, Zhi
Murata, Glen H
Sun, Yijuan
Glew, Robert H
Qualls, Clifford
Vigil, Darlene
Servilla, Karen S
Golper, Thomas A
Tzamaloukas, Antonios H
author_facet Xu, Zhi
Murata, Glen H
Sun, Yijuan
Glew, Robert H
Qualls, Clifford
Vigil, Darlene
Servilla, Karen S
Golper, Thomas A
Tzamaloukas, Antonios H
author_sort Xu, Zhi
collection PubMed
description AIM: To test whether muscle mass evaluated by creatinine excretion (EX(Cr)) is maintained in patients with end-stage kidney disease (ESKD) treated by peritoneal dialysis (PD), we evaluated repeated measurements of EX(Cr) in a PD population. METHODS: One hundred and sixty-six PD patients (94 male, 72 female) receiving the same PD dose for the duration of the study (up to approximately 2.5 years) had repeated determinations of total (in urine plus spent dialysate) 24-h EX(Cr) (EX(Cr) T) to assess the adequacy of PD by creatinine clearance. All 166 patients had two EX(Cr) T determinations, 84 of the 166 patients had three EX(Cr) T determinations and 44 of the 166 patients had four EX(Cr) T measurements. EX(Cr) T values were compared using the paired t test in the patients who had two studies and by repeated measures ANOVA in those who were studied three or four times. RESULTS: In patients who were studied twice, with the first and second EX(Cr) T measurements performed at 9.2 ± 15.2 mo and 17.4 ± 15.8 mo after onset of PD, respectively, EX(Cr) T did not differ between the first and second study. In patients studied three times and whose final assessment occurred 24.7 ± 16.3 mo after initiating PD, EX(Cr) T did not differ between the first and second study, but was significantly lower in the third study compared to the first study. In patients who were studied four times and whose fourth measurement was taken 31.9 ± 16.8 mo after onset of PD, EX(Cr) T did not differ between any of the studies. The average EX(Cr) T value did not change significantly, with the exception of the third study in the patients studied thrice. However, repeated determinations of EX(Cr) T in individuals showed substantial variability, with approximately 50% of the repeated determinations being higher or lower than the first determination by 15% or more. CONCLUSION: The average value of EX(Cr) T remains relatively constant for up to 2.5 years of follow-up in PD patients who adhere to the same PD schedule. However, repeated individual EX(Cr) T values vary considerably in a large proportion of the patients. Further studies are needed to evaluate the clinical significance of varying EX(Cr) T values and the stability of EX(Cr) T beyond 2.5 years of PD follow-up.
format Online
Article
Text
id pubmed-5500457
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Baishideng Publishing Group Inc
record_format MEDLINE/PubMed
spelling pubmed-55004572017-07-20 Reproducibility of serial creatinine excretion measurements in peritoneal dialysis Xu, Zhi Murata, Glen H Sun, Yijuan Glew, Robert H Qualls, Clifford Vigil, Darlene Servilla, Karen S Golper, Thomas A Tzamaloukas, Antonios H World J Nephrol Retrospective Study AIM: To test whether muscle mass evaluated by creatinine excretion (EX(Cr)) is maintained in patients with end-stage kidney disease (ESKD) treated by peritoneal dialysis (PD), we evaluated repeated measurements of EX(Cr) in a PD population. METHODS: One hundred and sixty-six PD patients (94 male, 72 female) receiving the same PD dose for the duration of the study (up to approximately 2.5 years) had repeated determinations of total (in urine plus spent dialysate) 24-h EX(Cr) (EX(Cr) T) to assess the adequacy of PD by creatinine clearance. All 166 patients had two EX(Cr) T determinations, 84 of the 166 patients had three EX(Cr) T determinations and 44 of the 166 patients had four EX(Cr) T measurements. EX(Cr) T values were compared using the paired t test in the patients who had two studies and by repeated measures ANOVA in those who were studied three or four times. RESULTS: In patients who were studied twice, with the first and second EX(Cr) T measurements performed at 9.2 ± 15.2 mo and 17.4 ± 15.8 mo after onset of PD, respectively, EX(Cr) T did not differ between the first and second study. In patients studied three times and whose final assessment occurred 24.7 ± 16.3 mo after initiating PD, EX(Cr) T did not differ between the first and second study, but was significantly lower in the third study compared to the first study. In patients who were studied four times and whose fourth measurement was taken 31.9 ± 16.8 mo after onset of PD, EX(Cr) T did not differ between any of the studies. The average EX(Cr) T value did not change significantly, with the exception of the third study in the patients studied thrice. However, repeated determinations of EX(Cr) T in individuals showed substantial variability, with approximately 50% of the repeated determinations being higher or lower than the first determination by 15% or more. CONCLUSION: The average value of EX(Cr) T remains relatively constant for up to 2.5 years of follow-up in PD patients who adhere to the same PD schedule. However, repeated individual EX(Cr) T values vary considerably in a large proportion of the patients. Further studies are needed to evaluate the clinical significance of varying EX(Cr) T values and the stability of EX(Cr) T beyond 2.5 years of PD follow-up. Baishideng Publishing Group Inc 2017-07-06 2017-07-06 /pmc/articles/PMC5500457/ /pubmed/28729968 http://dx.doi.org/10.5527/wjn.v6.i4.201 Text en ©The Author(s) 2017. Published by Baishideng Publishing Group Inc. All rights reserved. http://creativecommons.org/licenses/by-nc/4.0/ Open-Access: This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
spellingShingle Retrospective Study
Xu, Zhi
Murata, Glen H
Sun, Yijuan
Glew, Robert H
Qualls, Clifford
Vigil, Darlene
Servilla, Karen S
Golper, Thomas A
Tzamaloukas, Antonios H
Reproducibility of serial creatinine excretion measurements in peritoneal dialysis
title Reproducibility of serial creatinine excretion measurements in peritoneal dialysis
title_full Reproducibility of serial creatinine excretion measurements in peritoneal dialysis
title_fullStr Reproducibility of serial creatinine excretion measurements in peritoneal dialysis
title_full_unstemmed Reproducibility of serial creatinine excretion measurements in peritoneal dialysis
title_short Reproducibility of serial creatinine excretion measurements in peritoneal dialysis
title_sort reproducibility of serial creatinine excretion measurements in peritoneal dialysis
topic Retrospective Study
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5500457/
https://www.ncbi.nlm.nih.gov/pubmed/28729968
http://dx.doi.org/10.5527/wjn.v6.i4.201
work_keys_str_mv AT xuzhi reproducibilityofserialcreatinineexcretionmeasurementsinperitonealdialysis
AT murataglenh reproducibilityofserialcreatinineexcretionmeasurementsinperitonealdialysis
AT sunyijuan reproducibilityofserialcreatinineexcretionmeasurementsinperitonealdialysis
AT glewroberth reproducibilityofserialcreatinineexcretionmeasurementsinperitonealdialysis
AT quallsclifford reproducibilityofserialcreatinineexcretionmeasurementsinperitonealdialysis
AT vigildarlene reproducibilityofserialcreatinineexcretionmeasurementsinperitonealdialysis
AT servillakarens reproducibilityofserialcreatinineexcretionmeasurementsinperitonealdialysis
AT golperthomasa reproducibilityofserialcreatinineexcretionmeasurementsinperitonealdialysis
AT tzamaloukasantoniosh reproducibilityofserialcreatinineexcretionmeasurementsinperitonealdialysis